secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2022-06-13T23:59:59+00:00
Accession:  0001213900-22-032533
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx annual meeting elects directors, approves say-on-pay and auditor ratification
--------------------------------------------------------------------------------

- All six director nominees elected; Gus D. Halas received 4,000,363 votes withheld, highest among nominees.
- Advisory say-on-pay approved with 8,907,079 votes in favor vs 4,678,794 against.
- UHY LLP ratified as auditor for 2022 with 15,154,056 votes in favor, only 3,406 against.
- Record date April 14, 2022; 18,152,349 shares outstanding and entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390022032533/0001213900-22-032533-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390022032533/ea161459-8k_optimizerx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-032533

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer